A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic Arthritis [0.03%]
一项回顾性研究：对于使用苏金单抗治疗后效果不佳的活动性银屑病关节炎患者采用Ixekizumab治疗的有效性研究
Saman Darabian,Maziar Badii,Jan P Dutz et al.
Saman Darabian et al.
Objectives: This study aims to evaluate clinical responses in patients with active psoriatic arthritis who, despite secukinumab 300 mg subcutaneous monthly, are switched to ixekizumab 80 mg subcutaneous every four weeks. Methods: We conduct...
Acute Respiratory Distress Syndrome in a Carrier of an Interleukin-36 Receptor Antagonist Mutation With Generalized Pustular Psoriasis [0.03%]
IL-36受体拮抗剂突变携带者泛发性脓疱型银屑病患者的急性呼吸窘迫综合征
Avital Baniel,Efrat Bar-Ilan,Yuval Hilerowicz et al.
Avital Baniel et al.
Background: Generalized pustular psoriasis of von Zumbusch is a rare variant of psoriasis often accompanied by systemic, sometimes life-threatening, symptoms. Generalized pustular psoriasis sometimes arises in pregnancy. ...
Danielle Yee,April W Armstrong
Danielle Yee
The Role of Pain in the Lives of Patients with Psoriasis: A Qualitative Study on an Inadequately Addressed Symptom [0.03%]
银屑病患者疼痛状况定性研究——一个被忽视的症状指标的影响作用分析
Ashley M Snyder,Vanina L Taliercio,Lisa B Webber et al.
Ashley M Snyder et al.
Background: Patients with psoriasis commonly report experiencing severe sensory symptoms, and the burden of these symptoms can extend beyond unpleasant experiences to impair patients' health-related quality of life (HRQL). However, the symp...
Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients [0.03%]
免疫调节剂治疗的银屑病患者对BNT162b2疫苗的抗体反应
Felix Pavlotsky,Zvi Segal,Aviv Barzilai
Felix Pavlotsky
Background: Data regarding anti-COVID-19 vaccination efficacy in psoriasis patients treated with immune-modulatory medications are scarce. Objective: ...
Healthcare Providers Face Numerous Challenges in Treating Patients with Psoriasis: Results from a Mixed-Methods Study [0.03%]
对中国银屑病患者的医疗保健提供者的挑战性研究：定性和定量的混合方法研究结果
Suzanne Murray,Jeffrey Crowley,Melinda J Gooderham et al.
Suzanne Murray et al.
Background: The paradigm shift toward biologic medications in psoriasis care requires healthcare providers (HCPs) to become acquainted with mechanisms of action and safety profiles of these new treatments to confidently u...
Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry [0.03%]
银屑病患者皮损面积和严重程度指数的开发及在CorEvita银屑病登记队列中的验证
Wayne P Gulliver,Kyoungah See,Baojin Zhu et al.
Wayne P Gulliver et al.
Background: Dermatologists would benefit from an easy to use psoriasis severity assessment tool in the clinic. Objective: To develop ps...
Isadora O Gilli,Gabriela C da Silva,Victoria Mendes et al.
Isadora O Gilli et al.
Background: During the past decades, several unconventional strategies for controlling chronic inflammatory diseases, including psoriasis, have been developed. The use of probiotics has been gaining importance as an adjuv...
Palmoplantar Pustulosis has a Greater Disease Burden than Plaque Psoriasis: Real-World Evidence From the CorEvitas Psoriasis Registry [0.03%]
掌跖脓疱病的疾病负担大于银屑病皮损：来自CorEvitas银屑病登记处的真实世界证据
Mark G Lebwohl,Rose Anne Medeiros,Rachel H Mackey et al.
Mark G Lebwohl et al.
Background: Palmoplantar pustulosis (PPP) is a rare skin disease characterized by episodes of neutrophilic pustules on the palms of the hands and soles of the feet. Current treatments for PPP have limited efficacy, and th...
Can Serum Fetuin-A be Used as a Marker for Cardiovascular Involvement in Psoriatic Patients? [0.03%]
血清胎盘角蛋白能否用于银屑病心血管受累的标志物？
Hanan M Saleh,Aliaa S Sheha,Nardeen N Eskander et al.
Hanan M Saleh et al.
Background: Psoriasis is a systemic inflammatory disorder. It is associated with increased risk of developing other chronic health diseases such cardiovascular disorders. Fetuin A is a glycoprotein that is present in bloo...